We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

SFHG:NASDAQSamfine Creation Holdings Group Limited Analysis

Data as of 2026-07-16 - not real-time

$2.49

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Samfine Creation Holdings is trading at $2.49, just above its 20‑day SMA of $2.40 but still below the 200‑day SMA of $2.85, indicating a short‑term bounce within a longer‑term downtrend. The MACD has turned bullish (line = 0.012, signal = ‑0.007) yet the overall trend remains bearish, RSI sits at a neutral 53, and volume is on a decreasing trajectory, all pointing to limited upside momentum. Fundamentally, the company posts strong top‑line growth (22.5% YoY) but suffers from negative gross (19%) and operating margins, a steep max drawdown of 61%, and a debt‑to‑equity ratio above 100%, suggesting earnings and balance‑sheet stress.
Valuation metrics are cheap – price‑to‑sales of 0.06 and price‑to‑book of 1.53 – but the extreme volatility (≈67% 30‑day) and thin liquidity (average volume ~4,670, current volume 1,799) amplify risk, especially given the company’s exposure to multiple geographies and the specialty printing sector.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below 200‑day SMA and approaching resistance at $2.70
  • Decreasing volume and neutral RSI suggest waning buying pressure
  • High volatility and thin liquidity increase downside risk

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Revenue growth remains robust but margins are negative
  • Debt‑to‑equity over 100% limits financial flexibility
  • Valuation multiples are attractive relative to peers

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential upside if the company can improve profitability and restructure debt
  • Extreme greed sentiment may temporarily lift price despite fundamentals
  • Continued exposure to multiple markets adds both opportunity and risk

Key Metrics & Analysis

Financial Health

Revenue Growth22.50%
Profit Margin-11.67%
ROE-31.95%
ROA-8.03%
Debt/Equity116.04
P/B Ratio1.5
Op. Cash Flow$-21064036
Free Cash Flow$-27165732
Industry P/E30.9

Technical Analysis

TrendBearish
RSI53.3
Support$1.90
Resistance$2.70
MA 20$2.40
MA 50$2.45
MA 200$2.85
MACDBullish
VolumeDecreasing
Fear & Greed Index92.8

Valuation

GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.19
Volatility66.97%
Sector RiskMedium
Reg. RiskMedium
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.